Cargando…

Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study

A myriad of organ-specific complications have been observed with COVID-19. While racial/ethnic minorities have been disproportionately burdened by this disease, our understanding of the unique risk factors for complications among a diverse population of cancer patients remains limited. This is a mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borno, Hala T., Kim, Mi-Ok, Tolstykh, Irina, Lin, Amy, Hong, Julian C., Yousefi, Sasha, Zhang, Sylvia, McKay, Rana R., Harismendy, Olivier, Razavi, Pedram, Cinar, Pelin, Rugo, Hope, Koshkin, Vadim S., Rabow, Maya, Wang, Christine, Bailey, Adina, Small, Eric J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640901/ https://www.ncbi.nlm.nih.gov/pubmed/36344859 http://dx.doi.org/10.1007/s10903-022-01413-w

Ejemplares similares

COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry
por: Borno, Hala T, et al.
Publicado: (2022)

1571P COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium
por: Hong, J., et al.
Publicado: (2021)

Examining reporting and representation of patients with cancer in COVID‐19 clinical trials
por: Rabow, Maya, et al.
Publicado: (2021)

Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer
por: Borno, Hala T., et al.
Publicado: (2020)

Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?
por: Borno, Hala T., et al.
Publicado: (2020)

A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool
por: Borno, Hala T., et al.
Publicado: (2019)

Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials
por: Koshkin, Vadim S., et al.
Publicado: (2018)

COVID-19 disparities: An urgent call for race reporting and representation in clinical research
por: Borno, Hala T., et al.
Publicado: (2020)

Prostate cancer patients’ self-reported participation in research: an examination of racial/ethnic disparities
por: Palmer, Nynikka R., et al.
Publicado: (2021)

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study
por: Borno, Hala T., et al.
Publicado: (2022)

Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial
por: Borno, Hala T., et al.
Publicado: (2022)

The Distance Between Us: the COVID-19 Pandemic’s Effects on Burnout Among Resident Physicians
por: Natsuhara, Kelsey H., et al.
Publicado: (2021)

Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study
por: Wang, Elizabeth Y, et al.
Publicado: (2023)

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer
por: Jindal, Tanya, et al.
Publicado: (2023)

Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research
por: Koshkin, Vadim S., et al.
Publicado: (2018)

An unusual manifestation of diabetic ketoacidosis and acute colonic pseudo-obstruction
por: Natalini, Jake, et al.
Publicado: (2017)

Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
por: Koshkin, Vadim S., et al.
Publicado: (2021)

The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape
por: Koshkin, Vadim S., et al.
Publicado: (2019)

Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
por: Chien, A. Jo, et al.
Publicado: (2012)

A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strategy
por: Kaplan, Celia P., et al.
Publicado: (2018)

Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High‐intensity Aerobic and resistance exercise for Metastatic castrate‐resistant Prostate cancer
por: Kenfield, Stacey A., et al.
Publicado: (2021)

An Overview of PARP Inhibitors for the Treatment of Breast Cancer
por: Cortesi, Laura, et al.
Publicado: (2021)

Editorial: Radical cystectomy in bladder cancer patients
por: Koshkin, Vadim S., et al.
Publicado: (2022)

Amelioration of sexual adverse effects in the early breast cancer patient
por: Melisko, Michelle E., et al.
Publicado: (2010)

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis
por: Rugo, Hope S., et al.
Publicado: (2017)

Emerging treatment strategies for metastatic triple-negative breast cancer
por: Huppert, Laura A., et al.
Publicado: (2022)

Maternal Asian ethnicity and obstetric intrapartum intervention: a retrospective cohort study
por: Reddy, Maya, et al.
Publicado: (2017)

How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials
por: Borno, Hala T., et al.
Publicado: (2019)

Multidisciplinary Management of Pancreatic Cancer
por: Cinar, Pelin, et al.
Publicado: (2022)

An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study
por: Cedars, Benjamin, et al.
Publicado: (2019)

Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review
por: Idossa, Dame, et al.
Publicado: (2022)

HER2 expression in urothelial carcinoma, a systematic literature review
por: Scherrer, Emilie, et al.
Publicado: (2022)

Editorial: Methods in genitourinary oncology
por: Jang, Albert, et al.
Publicado: (2023)

Single-dose (177)Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
por: Aggarwal, Rahul, et al.
Publicado: (2023)

Androgen receptor gene expression in primary breast cancer
por: Vidula, Neelima, et al.
Publicado: (2019)

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
por: Shastry, Mythili, et al.
Publicado: (2022)

nsPEF-induced PIP(2) depletion, PLC activity and actin cytoskeletal cortex remodeling are responsible for post-exposure cellular swelling and blebbing
por: Tolstykh, Gleb P., et al.
Publicado: (2016)

High Prevalence of Rare Mutations in the Beta Globin Gene in an Ethnic Group in Iran
por: Galehdari, H, et al.
Publicado: (2011)

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lci5o443469qtatmqpgd97i4jl